Request Your Free White Paper Now:

"Addressing safety challenges with a new approach to real world data"

Safety is an ongoing challenge for the pharmaceutical and medical device industries. Despite the billions of dollars spent annually on clinical trials to identify adverse events before a drug or device enters the market, many only become evident after a product has reached the market.

Access this important whitepaper from Truveta today to explore real world data and how it is becoming a critical and effective part of the post-market surveillance process. You’ll discover:

• How to best cut through the noise that often comes with real world data
• What constitutes a real signal requiring deeper evaluation
• Key solutions for combining health data with advanced analytics to enable improved research on patient care and outcomes for any condition, drug, or medical device
• The latest innovative tools and data for detecting, monitoring and prioritizing safety signals faster and more accurately
• Strategies leading organizations like Pfizer are implementing to accelerate safety insights
• And more

Offered Free by: Truveta
See All Resources from: Truveta